Cytek Biosciences, Inc. (CTKB) Stock Grade

About Cytek Biosciences, Inc.'s fundamentals

Cytek Biosciences is a medical devices company with a market capitalization of $645.1 million that is currently unprofitable, reporting a net loss and a negative net margin of -33.0% in its latest annual statement. The company generated nearly flat revenue growth of 0.5% year-over-year, indicating minimal expansion in sales despite operating in the healthcare sector. With no dividend yield and profitability metrics unavailable, the company is reinvesting resources toward operations rather than returning capital to shareholders.